The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen ...

Growth stocks can help to supercharge your investment portfolio and boost your retirement fund. The key, however, is to ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...

Teva and Sanofi's duvakitug showed promising results in a Phase 2b study for ulcerative colitis and Crohn's disease, with ...

Sanofi has shared a deeper dive into its 469 million euro ($491 million) bowel disease bet, publishing phase 2 data that ...

Warren Buffett explained why Berkshire Hathaway will always prefer equity investments to cash, why the firm's investments in Japanese conglomerates is likely to increase, and the traditions he expects ...

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transfo ...

Sarclisa approved in Japan for patients with newly diagnosed multiple myeloma Approval offers access to new treatment options for newly diagnosed MM patients Approval based on positive results from ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today reported financia ...

More than a third (33%) of essential generic medicines were withdrawn from the Portuguese market in the last ten years, ...